Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
11M
-
Shares change
-
+1.76M
-
Total reported value, excl. options
-
$82.4M
-
Value change
-
+$14.1M
-
Put/Call ratio
-
0.26
-
Number of buys
-
40
-
Number of sells
-
-17
-
Price
-
$7.46
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q2 2021
63 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q2 2021.
Summit Therapeutics Inc. - COM (SMMT) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11M shares
.
Largest 10 shareholders include Polar Capital Holdings Plc (6.96M shares), BlackRock Inc. (1.1M shares), VANGUARD GROUP INC (880K shares), BAILLIE GIFFORD & CO (437K shares), STATE STREET CORP (257K shares), GEODE CAPITAL MANAGEMENT, LLC (222K shares), MORGAN STANLEY (218K shares), RENAISSANCE TECHNOLOGIES LLC (125K shares), UBS Group AG (125K shares), and FIL Ltd (104K shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.